NCT07715500 Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications
| NCT ID | NCT07715500 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of Liver and Biliary Sciences, India |
| Condition | Chronic Liver Disease and Cirrhosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-07-01 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Living donor liver transplantation is widely accepted as an life-saving treatment for patients with end-stage liver diseases. Careful donor selection is essential to maximize the success and minimize the risk of postoperative complications in donors and recipients. Mapping of biliary anatomy is one of the critical assessments for donor selection and surgical planning ,Biliary reconstruction is considered as the "Achilles heel" of liver transplantation and adequate imaging assessment of biliary anatomy can largely benefit the biliary anastomosis. Preoperative imaging assessment of biliary anatomy is good for the selection of donors but may not indispensable for surgical planning and Intraoperative confirmative assessment of biliary anatomy with IOC was essential
Eligibility Criteria
Inclusion Criteria: * All prospective voluntary healthy liver donor of age 18-55 Exclusion Criteria: * Type C/D Portal vein anatomy * Left sided Gallbladder * Right Posterior Graft * Recipients undergoing Hepaticojejunostomy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07715500 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Chronic Liver Disease and Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07715500 currently recruiting?
Yes, NCT07715500 is actively recruiting participants. Contact the research team at atulrenjit@gmail.com for enrollment information.
Where is the NCT07715500 trial being conducted?
This trial is being conducted at New Delhi, India.
Who is sponsoring the NCT07715500 clinical trial?
NCT07715500 is sponsored by Institute of Liver and Biliary Sciences, India. The trial plans to enroll 100 participants.